Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?Review Article Published on 2024-03-212024-09-05 Journal: Allergologie Select [Category] update2024, [키워드] Biologicals Chronic rhinosinusitis CRSwNP eosinophilic inflammation mepolizumab [DOI] 10.5414/ALX02460E PMC 바로가기 [Article Type] Review Article
Eosinophil granulocytes in chronic inflammatory respiratory diseases and CRSwNP: Function, immunological basis, and clinical significanceReview Article Published on 2024-03-212024-09-05 Journal: Allergologie Select [Category] update2024, [키워드] allergic rhinitis Asthma benralizumab Biologicals CRSwNP eosinophils mepolizumab mucositis reslizumab [DOI] 10.5414/ALX02469E PMC 바로가기 [Article Type] Review Article
Serological response to vaccines against SARS-CoV-2 in patients with inflammatory bowel diseaseObservational Study Published on 2023-01-012023-07-09 Journal: Gastroenterología y hepatología [Category] COVID19(2023년), [키워드] Biologicals Biológicos COVID-19 Enfermedad inflamatoria intestinal Inflammatory bowel disease SARS-CoV-2 vaccine Vacuna infección SARS-CoV-2. [DOI] 10.1016/j.gastrohep.2022.05.006 PMC 바로가기 [Article Type] Observational Study
[History of reactive arthritis. Historical milestones and future]Article Published on 2022-10-012022-11-15 Journal: Zeitschrift Fur Rheumatologie [Category] COVID19(2023년), SARS, 치료제, [키워드] Antiviral Arthritis assigned association Bacterial pathogens Biologicals causative pathogen classical Clinical features Combination antibiotics comparable described Diagnostic Criteria disease English HLA-B27 Infection joint joint inflammation molecular pandemic Patient Perspective polymerase chain Post-COVID-19 arthritis Postinfectious Postinfectious arthritis reactive SARS-CoV‑2 Sexually acquired reactive arthritis. synovial Trigger two group vaccination viruses Yersinia [DOI] 10.1007/s00393-022-01253-x PMC 바로가기
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19비스테로이드성 소염제 및 기타 에이코사노이드 경로 조절제가 항바이러스 및 알레르기 반응에 미치는 영향: COVID-19 시대의 에이코사노이드 합의 보고서에 대한 EAACI 태스크포스Article Published on 2022-08-012022-09-11 Journal: Allergy [Category] COVID19(2023년), SARS, 치료제, [키워드] allergic allergic diseases allergic inflammation allergy analgesic effect antagonist Anti-inflammatory anti-inflammatory drug Antipyretic Antiviral applied Asthma Biologicals biologicals. cannabinoids chronic inflammatory disease Consensus COVID-19 COVID-19 treatment Effect eicosanoid General population Horizon identify Inflammation Inflammatory diseases Interaction knowledge leukotriene leukotriene receptor antagonist leukotriene receptor antagonists LTRA mechanism mechanism of action medication medications NERD non-steroidal anti-inflammatory drug Non-steroidal anti-inflammatory drugs NSAID NSAIDS pandemic of COVID-19 pathway Pathways predict prostaglandin prostaglandin D2 Research Respiratory disease respiratory infections response SARS-CoV-2 selectivity Symptom therapy Treatment unmet need viral infection viral infections [DOI] 10.1111/all.15258 PMC 바로가기 [Article Type] Article
Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease종양 괴사 인자-α 길항제의 사용은 염증성 장 질환이 있는 백신 접종 환자에서 SARS-CoV-2에 대한 약화된 IgG 항체 반응과 관련이 있습니다Observational Study Published on 2022-07-052022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술, [키워드] Against age antagonist antagonists anti-SARS-CoV-2 antibody anti-SARS-CoV-2 vaccination antibody Antibody concentrations Antibody titer Antibody titers Biologicals Blood blood sampling bowel Characteristics clinical Clinical characteristics Combination completion Concentration COVID-19 Crohn's disease defined demonstrated detectable disease Effect elapsed geometric geometric mean IBD IgG IgG antibodies IgG antibody IgG antibody titer IgG antibody titers immune response immunoassay immunomodulating Immunosuppressive medication immunosuppressive medications increased risk independent independent of Inflammatory Inflammatory bowel disease medication Microparticle monotherapy Most patients mRNA mRNA vaccines mRNA-based vaccine mRNA-based vaccines Multivariable models Patient patient age patients patients treated prospective observational cohort quantitative determination RBD receive receiving Receptor-binding domain regimen response S1 subunit sampling SARS-CoV-2 SARS-COV-2 infection Seroconversion serological response significantly lower Spike protein the receptor-binding domain the S1 subunit the spike protein titer TNF-α-antagonists treated Treatment Tumor ulcerative colitis vaccination Vaccine vector was used were measured were recorded [DOI] 10.3389/fimmu.2022.920333 PMC 바로가기 [Article Type] Observational Study
COVID‐19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendationsArticle Published on 2022-03-182023-06-15 Journal: Allergy [Category] MERS, SARS, [키워드] allergen allergy Biologicals COVID‐19 Immunotherapy mRNA vaccines [DOI] 10.1111/all.15252 PMC 바로가기
Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 PandemicObservational Study Published on 2021-12-012022-10-05 Journal: Digestive diseases and sciences [Category] 임상, [키워드] adherence adopted agent Biological Biologicals bowel Care clinical Clinical outcome Cohort collected combination therapy confirmed COVID-19 case COVID COVID-19 COVID19 cumulative drugs fear FIVE global pandemic hospital hospitals IBD immunosuppressants incidence Inflammatory bowel disease intravenous intravenous infusion measure Mild outbreak pandemic participated Patient perceptions performed Registered severity single-center the patient the SARS-CoV-2 therapy treated Treatment withdrawn [DOI] 10.1007/s10620-020-06807-0 PMC 바로가기 [Article Type] Observational Study
COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) – A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA)Research Article Published on 2021-04-012022-10-28 Journal: Allergologie Select [Category] COVID-19, [키워드] acute respiratory syndrome adjusted allergic allergic reaction allergology allergy antibodies antibody approved Asthma atopic atopic dermatitis atopy Biological Biologicals bronchial asthma caused clinical concomitant treatment condition coronavirus COVID-19 COVID-19 vaccination disease Germany immune stimulation immunological immunomodulatory immunomodulatory drug increased risk indicated Inflammation Inflammatory Interaction interval material monoclonal antibodies nasal paper Patient patients Paul Ehrlich performed potential risk provide Reactions receiving recommendation SARS-CoV-2 SARS-CoV-2 vaccination Society therapy Treatment vaccination Vaccine Vaccines worldwide pandemic [DOI] 10.5414/ALX02241E PMC 바로가기 [Article Type] Research Article
Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of OmalizumabReview Published on 2021-03-302022-10-28 Journal: Biomedicines [Category] COVID-19, [키워드] Activation acute respiratory syndrome addition Allergic asthma Antiviral effect appear aspect Asthma asthma patient Biologicals cellular children Clinical efficacy coronavirus Course effector cells form IgE immune response increased risk Infection Inflammatory initial Innate immunity interferon management monoclonal antibody occur omalizumab progression Protective respiratory infection respiratory viral infections risk factor role SARS-CoV-2 SARS-COV-2 infection Severe asthma susceptible Th2 treated type I viral infection viral respiratory infections viral spread viruses [DOI] 10.3390/biomedicines9040348 PMC 바로가기 [Article Type] Review